Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Terminated 5Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1Colorectal Neoplasms 1

Interventions

Dexamethasone 15daratumumab 13Lenalidomide 9Bortezomib 8pomalidomide 6Calcium Dobesilate 5Cyclophosphamide 4carfilzomib 3belantamab mafodotin 3tocilizumab 2isatuximab 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Specimen Handling 2Melphalan 2Maintenance 2Exercise Therapy 2Drug Therapy 2CT103A chimeric antigen receptor 2Biopsy 2zanubrutinib 1trametinib 1talquetamab 1selinexor 1pembrolizumab 1ixazomib 1ibrutinib 1iberdomide 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Multiple Myeloma × Flow Cytometry × Clear all
NCT06925958 2025-04-13

A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma

The First Affiliated Hospital of Soochow University

Phase NA Not yet recruiting
15 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡